The European Research Council has granted an ERC Starting Independent Researcher Grant to Academy Research Fellow Ville Hietakangas from the Institute of Biotechnology. The five-year grant totals approximately EUR 1.5 million. Ville Hietakangas is delighted as the grant allows for goal-orientated work in the long term.

– This type of funding is extremely important to a recently established team of researchers. It enables us to fully focus on the issues that I think are essential in our field, he says.

With his team, Hietakangas studies the messages that the organism of a fruit fly sends about its nutritional status. Among other things, the team has discovered a genetic mutation in a fly that severely disturbs glucose metabolism. The reason for the metabolic imbalance remains partly unclear, which makes this mutation and its exceptional glucose metabolism an interesting discovery in terms of further research.

The team is interested in communication within organisms: how does an organism use the information it collects to control metabolism?

The project that was awarded the funding focuses on detecting glucose and the related gene regulation. The goal is to find new gene regulators that contribute to glucose metabolism.

Metabolic diseases are increasing

Fruit flies have been used for research in experimental biology for more than a hundred years. They are also suitable for metabolism research. The fruit fly is an excellent model system, because its genes can be switched on and off in any specific tissue. It also enables broad genetic screens as raising flies is relatively inexpensive and fast.

Although people and fruit flies differ in appearance, their metabolic systems and many other cell-level functions have remained quite similar throughout evolution.

– Our work involves basic research in biology, but the results may benefit the development of treatments for diabetes and other metabolic diseases in the long run, says Hietakangas.

Metabolism research is growing in significance, because morbid obesity and related metabolic diseases are becoming more common around the world.

Through its Starting Independent Researcher Grants, the European Research Council supports young researchers who are in the process of establishing a research team or finding stability for a project that has been running for a few years. Hietakangas is the third recipient of an ERC Starting Independent Researcher Grant at the University of Helsinki this autumn.

Ville Hietakangas’ research team »»

 
 
The European Research Council has awarded an ERC Starting Independent Researcher Grant to Anna-Liisa Laine, who works as a group leader at the Finnish Centre of Excellence in Metapopulation Research. The five-year grant totals EUR 1.5 million. Academy Research Fellow Anna-Liisa Laine and her team study the complex relationship between the ribwort plantain Plantago lanceolata and the powdery mildew Podosphaera plantaginis in the meadows of the Åland Islands. The powdery mildew infects the ribwort plantain, sucking nutrients from its cells. The two form a natural model system that explains the behaviour of plant diseases on a wider scale. The research results shed light on the reasons behind plant diseases and the variation in their infection ability.

A unique database

In her research, Laine exploits the same network of meadows that Academy Professor Ilkka Hanski used in his famous metapopulation studies on the Glanville Fritillary. The ribwort plantain, which is the only host plant for the powdery mildew, is also the primary food plant for the caterpillars of the Glanville Fritillary.

The 4,000-plus known ribwort plantain populations in the Åland Islands have now been examined for occurrences of the powdery mildew. Accumulated over a period of ten years, this data constitutes a unique database, even globally.

The Åland Islands offer an opportunity to study the evolutionary processes of diseases in natural conditions. The results from laboratory studies in Viikki during the winter are tested in the field during the growth season.

Farming is likely to benefit from the results

In the long term, farming in particular may benefit from the research into the factors affecting the evolution of diseases. The research project has produced models for predicting the occurrence of diseases. These models can be adapted to measure economically significant plant diseases.

– Chemical pesticide sprayings are partly random, because the real disease risks remain unknown. Reliable predictions of the time and place of disease risks would enable a considerable decrease in pesticide use, says Laine.

Laine and her team are also developing methods that make it easier to study parasitic fungi. Successful cryo freezing, for example, keeps the spores viable for a long time.

Last spring, the researchers in the project examined overwintered powdered mildew for the first time. The purpose was to identify the factors affecting the wintering of mildew. This information may shed new light on the wintering of disease populations in general as to date this has not been studied much.

– Winter ecology is regulated by entirely different factors than successful growth seasons, Laine says.

Academy Research Fellow Anna-Liisa Laine’s homepage »»

 
 
Ark Therapeutics Group plc is pleased to announce it has received notice of the award of a €5.3 million EU Framework Programme 7 Grant to a consortium led by Ark including two other SMEs and elements of the Yale-UCL Research Collaborative (Division of Medicine in UCL, and Departments of Cardiology in Yale and Queen Mary College London) and the University of Eastern Finland.

The Grant supports the consortium’s involvement in a research programme to translate cutting edge biotechnology in the coronary stent area over four years. The Grant is subject to the formal process of contract negotiation with the European Commission (“EC”) which is anticipated to reach conclusion in September. Ark’s successful grant application was chosen from more than 40 applications across Europe and received an overall score of 13.5 out of a possible 15 from the EC's independent scientific report on the project’s technology.

The Grant will fund research that combines the technologies of the participants:

1)      Ark's technology and expertise concerning adenoviral-delivered gene therapeutics, which will be delivered to the coronary artery after heart attack to restore the integrity of the artery; and

2)      Use of a pro-healing and/or regenerative stent (in collaboration with Magnus Inventions and QualiMed, a German company which will make the stent).

The objective of the project will be to stimulate a healing process such that over time the stent will undergo a predictable degradation to leave a wholly biologically healed artery through regeneration of native tissues. The research programme is scheduled to commence in November this year and Ark will receive €1.1 million for its contribution to the project.

Martyn Williams, Chief Executive of Ark commented: “The award to Ark of this significant EU grant further demonstrates the Company’s innovative science capabilities and validates the approach of gene therapy and stem cell therapy in the cardiovascular system. We welcome the opportunity to collaborate with so many respected institutions and look forward to contributing to such an important disease area.”

Professor John Martin, Chief Scientific Officer at Ark commented: “Grants, such as the EU Framework Grant announced today, provide much needed resources to carry out important research into areas where there is significant unmet need. We hope that this research will offer new hope to sufferers of heart disease, a condition that affects more than 50% of the population during their lifetime.”

 
 
来源:科技部通知

七部委印发国家中长期科技人才发展规划

逐步取消高等学校、科研机构行政级别,克服行政化倾向  

根据《国家中长期人才发展规划纲要(2010-2020年)》(以下简称《人才规划纲要》)、《国家中长期科学和技术发展规划纲要(2006-2020)》(以 下简称《科技规划纲要》)和《国家中长期教育发展和改革规划纲要(2010-2020年)》(以下简称《教育规划纲要》)的总体要求,为加快建设人才强 国,实现建设创新型国家和全面建设小康社会奋斗目标提供科技人才保证,科技部、人力资源和社会保障部、教育部 、中国科学院、中国工程院、国家自然科学基金委员会和中国科协共同制定《国家中长期科技人才发展规划(2010-2020年)》(以下简称《科技人才规划》)。   根据《科技人才规划》,到2020年,我国科技人才发展的主要目标是:建设一支规模宏 大、素质优良、结构合理、富有活力的创新型科技人才队伍,合理提高人力成本在研发经费中的比例,确立科技人才国际竞争优势,为实现我国进入创新型国家行列 和全面建设小康社会的目标提供科技人才支撑。   在体制机制创新方面,将通过试点先行、以点带面,全面推进我国科技人才管理体制机制的深化改革,建立有利于创新人才成长和发展的体制机制。逐步取消高等学校、科研机构的行政级别,克服高等学校、科研机构的行政化倾向。   建立科研机构创新绩效综合评价制度,引导科研机构和高等学校等建立以科研质量和创新能力 为导向的科技人才评价标准。对从事基础研究的人才,重在以同行评议国际通用的评价方式,考核其学术水平和学术影响;对从事社会公益研究的科技人才,重在考 核其为社会公益事业和政府决策提供科技支撑的能力和贡献;对从事应用研究和技术开发的科技人才,重在考核其技术创新与集成能力,获得的自主知识产权等;对 于从事实验技术和条件保障的科研辅助人才,重在考核其为研发活动提供的服务水平、工作质量。对从事管理和服务的科技管理人才,重在考核其管理水平和服务能 力与效率。   根据我国科技发展需要,不断改进和完善院士制度,充分发挥院士称号的精神激励作用,规范院士学术兼职。

附件:国家中长期科技人才发展规划(2010-2020年)
 
 
日前,人力资源和社会保障部发布《留学人员回国工作“十二五”规划》,提出“十二五”期间,留学回国人员新增人数将达到50万人以上。   规划提出,“十二五”期间,吸引留学人员为国服务30万人次;新建各级、各类留学人员创业园50个,全国总量达到200个,其中人力资源和社会保障部与地方人民政府共建留学人员创业园达到50个左右,留学人员入园企业总量达到15000家。   规划明确,将从五个重点领域引进海外留学人才:海外顶尖人才和高层次创新型科技人才,产业领军人才和经济发展重点领域急需紧缺人才,农业科技领军人才和急需紧缺人才,现代服务业急需紧缺人才,社会发展重点领域急需紧缺人才。   “十二五”期间,将健全留学人员回国工作机制,完善留学人员回国政策体系,健全留学人员回国服务体系,加强海外高层次人才引进工作,促进留学人员回国创业,鼓励海外人才以多种形式为国服务。
 
 
转自千人计划网

根据《青年海外高层次人才引进工作细则》的规定,海外高层次人才引进工作专项办公室组织实施了第一批“青年千人计划”申报评审工作。经初审、通信评审、面试评审,共有152名人选通过评审,现予以公示,公示期14天。

  公示期间,若对人选的资格条件等有异议,请于9月2日之前将有关意见发至专项办邮箱zhuanxiangban@1000plan.org

  附件:第一批“青年千人计划”公示人选名单.doc

 
 
 
September call for applications out now (20.7.2011)

The Academy of Finland’s September 2011 call for applications has now been published on the Academy’s website. The Finnish-language version was published in early July. Applications for the September 2011 call can be drafted and submitted in the Academy’s online services from 6 September 2011 through to 30 September 2011. International calls may have different deadlines and these are indicated in the call for applications.

Applicants are requested to draft their research plans and lists of publications according to the revised guidelines.

The Academy has introduced new application dates. The annual calls are now in September and April. In September, applications are invited for, for example, Academy Projects and research posts (Academy Professors, Academy Research Fellows and Postdoctoral Researchers). Advance information on the April call is available in the call for applications.

Funding open for application in September 2011:

For research

  • Academy Projects, all research fields
  • Targeted Academy Projects
    • Development research
    • Sustainable economy
    • Wireless data transfer
    • Wireless networks research (Academy of Finland, Tekes, NSF)
    • Nuclear technology
Joint calls with international funding agencies

  • Biosciences and environmental research (Academy of Finland, JSPS)
  • Investigator-driven clinical trials (Academy of Finland, Swedish Research Council)
  • Materials science and engineering research (Academy of Finland, NSF)
  • Ageing research: ERA-AGE 2 JCRA
  • Joint Programme in Neurodegenerative Diseases (JPND), pilot call
  • Academy research programmes
    • Sustainable Management of Aquatic Resources (AKVA), letters of intent
    • Programmable Materials (OMA), letters of intent
    • Computational Science (LASTU), full applications
For researchers

  • Academy Professors 
  • Academy Research Fellows 
  • Postdoctoral Researchers 
  • Special funding for researchers
    • Clinical researchers
    • International researcher mobility based on bilateral agreements
      • Fellowships of foreign funding agencies: JSPS Fellowship to Japan, CAS Fellowship to China
      • European Research Council (ERC) calls 
For research environments

  • Finland Distinguished Professor Programme (FiDiPro), letters of intent


More information:

The Academy of Finland will move on 1–2 September 2011. We will be closed during the move. Our email addresses will not change. 

Academy of Finland Communications
Communications Specialist Vesa Varpula
tel. +358 9 7748 8458
vesa.varpula(at)aka.fi

Last changed 20/07/2011
 
 


2011年度国家自然科学基金委员会(NSFC)与德国科学基金会(DFG)、芬兰科学院(AF)在免疫学领域共同资助合作研究项目。经公开征集, 共收到申请23项。根据我委有关规定和与德国、芬兰方面核对申请项目清单,共有14项申请通过初审,现将初审结果予以公布如下:
  序号 申请项目名称 中方申请人/依托单位 德方合作者/依托单位 芬兰合作者/依托单位

1 自身免疫调节:寻找共享致病机制和疾病特征性标记  
严冰   四川大学 
Georg Fuellen    Institute for Biostatistics and Informatics in Medicine and Ageing Research, University of Rostock 
Yrjö Tapio Konttinen   Institute of Clinical Medicine, University of Helsinki

2 淋巴管 - 细胞迁移和免疫调节的新靶点  
朱明昭  中国科学院生物物理研究所
Oliver Pabst Hannover Medical School
Sirpa Jalkanen University of Turku

3 前列腺癌的肿瘤免疫:以CD40/CD40L互作为基础的新治疗方法 
李向东 中国农业大学
Andreas Thiel Berlin-Brandenburg Center for Regenerative Therapies
Nafis Rahman Dep. of Physiology, Institute of Biomedicine, University of Turku, Finland

4 人工合成多价免疫调节性寡糖与环多肽:合成与作用机制  
刘和文 中国科学技术大学
Harald Renz Philipps University Marburg, Germany
Johannes Savolainen  University of Turku, Finland

5 溶瘤腺病毒和脂质体纳米颗粒介导的肿瘤免疫反应研究:前临床模型及临床高级治疗途径下的胰腺癌和肝癌国际合作科研项目   李兰娟  浙江大学
Holger Kalthoff Institut für Experimentelle Tumorforschung,UKSH, Campus Kiel
Kalevi Kairemo Molecular Radiotherapy & Nuclear Medicine, International Comprehensive Cancer Center Docrates

6 血小板在结核病发生过程中作用机制研究  
戈宝学  同济大学
Anca Dorhoi Max Planck Institute for Infection Biology
Seppo Meri Department of Bacteriology and Immunology, Haartman Institute, University of Helsinki

7 由纳米粒子和纳米管介导的激光光治疗的抗肿瘤免疫研究  
陈同生 华南师范大学
Martina Meinke Department of Dermatology, Charité, Universitätsmedizin Berlin
Valery Tuchin Optoelectronics and Measurement Techniques laboratory, University of Oulu

8 抑制性巨噬细胞在神经系统自身免疫性和退行性慢性炎症中的功能和机制  
张志仁  中国人民解放军第三军医大学
Hermann Schluesener   Department of Neuropathology, Tuebingen University Germany
Kai Kaarniranta  Department of Ophthalmology; School of Medicine, University of Eastern Finland,

9 特定农村环境中儿童期哮喘保护性免疫调节机制的多中心研究  
李靖 广州医学院
Bianca Schaub the Asthma and Allergy Department and Pulmonary Department of Munich, University Children's Hospital
Marjut Roponen Department of Environmental Science, University of Eastern Finland

10 基于选择性降低抗原的稳定性研制高校疫苗:以鼠疫耶尔森氏菌F1抗原为模型
杨瑞馥 中国人民解放军军事医学科学院  
Timo Korpela Department of Chemistry, University of Turku,Finland

11 维生素D、A补充对糖尿病前期人群免疫功能和胰岛素抵抗的影响及机制研究  
马爱国 青岛大学   
Qing Qiao Univ. of Helsinki, Finland

12 细胞因子信号转导通路的调节机制研究  
姚智 天津医科大学   
Olli Silvennoinen Institute of Biomedical Technology, University of Tampere

13 抗体与白介素18融合分子抗日本血吸虫病肝纤维化的分子机制研究  
汪世平 中南大学  
Zoltán Konthur Max Planck Institute for Molecular Genetics  

14 癌睾丸抗原特异性抗体及T细胞介导的过继免疫治疗多发性骨髓瘤的合作研究  
王月丹 北京大学
Djordje Atanackovic     University Medical Center Hamburg-Eppendorf, Hamburg, Germany  

  联系人:

  国际合作局西欧处 徐进 范英杰

  电 话:010 6232 5351

      010 6232 5309

  传 真:010 6232 7004

  Email:xujin@nsfc.gov.cn fanyj@nsfc.gov.cn
 
 


转自Turku学联

为配合图尔库“2011欧洲文化之都“的宣传活动,在中国驻芬兰大使馆及Turku市政府的大力支持下,Turku中国学生学者联谊会组队参加了每 年在Turku影响最大的群众体育活动-Paavo Nurmi马拉松。Paavo Nurmi 是芬兰长跑界的传奇人物,共获得过9枚奥运会金牌,以他的名字命名的马拉松比赛已经有20年的历史,每年都会吸引包括顶级运动员在内众多长跑爱好者参加, 今年更是有3000多人报名参赛,其中24名中国留学生的集体闪亮登场,无疑是本次活动的一大亮点。

Turku学联提前3个月开始了组队报名工作,经过充分的准备,7月2号下午1点整,他们统一身着图尔库“2011欧洲文化之都“的宣传T恤,精神 饱满的亮相在起跑线上,使馆教育组宗刚老师到现场为参赛中国学生加油鼓劲。比赛当天正逢Turku的中世纪狂欢节,当地居民也涌上街头,为运动员呐喊助 威。比赛过程中,经常有热情的芬兰朋友高喊”中国”的声音,并为参赛选手击掌打气,留学生们备受振奋和鼓舞。比赛当天虽然气温高达近30度,但所有参赛的 中国留学生都坚持完成了比赛,顽强的意志品格也赢得了其他国家参赛选手的肯定。

本次比赛,参赛的中国选手向芬兰人民充分展现了在Turku的中国留学生积极向上,活泼健康的精神风貌,大力宣传了中芬之间良好的国际合作关系,加深了芬兰人民对中国的认识和了解,为进一步增进两国人民之间的友谊作出了自己的贡献。

  比赛结束后,宗刚老师,图尔库学者代表王栋和何秋水老师,以及图尔库学联,全芬化学化工研究会,全芬篮球协会,公派留学生及所有参赛运动员欢聚一 堂,宗老师赞扬了所有参赛运动员坚持完成比赛的决心和毅力,肯定了学联的组织工作,同时为学联社团的未来工作提出了很多建设性意见,他不但给我们带来了使 馆的关心与期望,还给马拉松比赛中表现突出的运动员带来了非常精美的奖品,获奖的同学格外惊喜,整个聚会气氛轻松热烈,图尔库的学生学者度过了一个非常难 忘的马拉松周末。

 
 
   据科技部网站消息,为贯彻《国民经济和社会发展第十二个五年规划纲要》,深入实施中长期科 技、教育、人才规划纲要,充分发挥科技进步和创新对加快转变经济发展方式的重要支撑作用,按照国务院的部署要求,科学技术部会同国家发展和改革委员会、财 政部、教育部、中国科学院、中国工程院、国家自然科学基金委员会、中国科协、国家国防科技工业局等有关单位,研究制定了《国家“十二五”科学和技术发展规 划》(以下简称“规划”)。   根据“规划”,“十二五”期间科技发展的总体目标是:自主创新能力大幅提升,科技竞争力和 国际影响力显著增强,重点领域核心关键技术取得重大突破,为加快经济发展方式转变提供有力支撑。基本建成功能明确、结构合理、良性互动、运行高效的国家创 新体系,国家综合创新能力世界排名由目前第21位上升至前18位,科技进步贡献率力争达到55%,创新型国家建设取得实质性进展。

《国家“十二五”科学和技术发展规划》全文